Private equity firm Creador is in advanced talks to acquire a stake. The firm expects to invest ₹800 crore in Leeford Healthcare. This acqu...

In a social media post, Puri welcomed the CPP workforce to ITC, saying the integration brings together two enterprises with a shared commit...

The ethanol story started simply enough: Cut India's dependence on imported crude oil. It would save foreign exchange. Give farmers a new a...

Employees skipping annual health checkups face triple the hospitalization risk. This group also accounts for a large share of insurance cla...

India's festive shopping season is set to highlight the country's premiumisation boom despite global uncertainty triggered by the US-Iran w...

Sun Pharma Q1 Results: Sun Pharma reported a 27% YoY rise in Q1 net profit to Rs 2,895 crore, while revenue grew 10% to Rs 15,300 crore, dr...

Following the sharp re-rating in small- and midcaps, Axis Mutual Fund has urged investors to revisit largecaps, saying their valuations hav...

The next time uncertainty over the firing of missiles in the Gulf region makes you anxious, remember this: It is not the first time that gl...

Motilal Oswal Private Wealth favors Indian mid and small-cap stocks. They are increasing allocations to these segments by ten percentage po...

Kazakhstan's ambassador expressed keen interest in expanding business engagement with West Bengal. The nation views West Bengal as a crucia...

Industry stakeholders say the opportunity for them lies in strengthening the link between its large industrial base and MSMEs while reducin...

Sanofi has launched AccelRare, an AI tool aiding doctors in rare disease pre-diagnosis. This platform generates potential diagnoses within ...

The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...

Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...

India's pharma and healthcare sector recorded 65 deals worth $13.9 billion in Q2 CY2026, with volumes falling 17% quarter-on-quarter to a f...

Akums Drugs and Pharmaceuticals will acquire Oriflame India's manufacturing business. This significant deal is valued at fifty-six crore ru...

Donald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...